| Date | Event |
| 10-Nov-09 | GENEREX BIOTECHNOLOGY CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or |
| 30-Oct-09 | GENEREX BIOTECHNOLOGY CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits |
| 20-Oct-09 | GENEREX BIOTECHNOLOGY CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits |
| 15-Oct-09 | GENEREX BIOTECHNOLOGY CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and E |
| 14-Oct-09 | GENEREX BIOTECHNOLOGY CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits |
| 1-Oct-09 | GENEREX BIOTECHNOLOGY CORP Files SEC form 8-K, Other Events |
| 15-Sep-09 | GENEREX BIOTECHNOLOGY CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and E |
| 6-Aug-09 | GENEREX BIOTECHNOLOGY CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and E |
| 16-Jun-09 | GENEREX BIOTECHNOLOGY CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and E |
| 9-Jun-09 | GENEREX BIOTECHNOLOGY CORP Files SEC form 10-Q, Quarterly Report |
| 5-Jun-09 | Price hit new 52-week high ($1.14) |
| 18-May-09 | GENEREX BIOTECHNOLOGY CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and E |
| 28-Apr-09 | Price hit new 52-week high ($0.70) |
| 27-Apr-09 | Price hit new 52-week high ($0.68) |
| 6-Apr-09 | GENEREX BIOTECHNOLOGY CORP Files SEC form 8-K, Other Events |
| 27-Mar-09 | GENEREX BIOTECHNOLOGY CORP Files SEC form 8-K, Entry into a Material Definitive Agreement |
| 20-Mar-09 | GENEREX BIOTECHNOLOGY CORP Files SEC form 8-K, Entry into a Material Definitive Agreement |
| 11-Mar-09 | GENEREX BIOTECHNOLOGY CORP Files SEC form 10-Q, Quarterly Report |
| 9-Mar-09 | Price hit new 52-week low ($0.08) |
| 6-Mar-09 | Price hit new 52-week low ($0.10) |
| 2-Mar-09 | GENEREX BIOTECHNOLOGY CORP Files SEC form 8-K, Triggering Events That Accelerate or Increase a Direct Financial Oblig |
| 2-Mar-09 | Price hit new 52-week low ($0.13) |
| 17-Feb-09 | GENEREX BIOTECHNOLOGY CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and E |
| 23-Dec-08 | GENEREX BIOTECHNOLOGY CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and E |
| 9-Dec-08 | GENEREX BIOTECHNOLOGY CORP Files SEC form 10-Q, Quarterly Report |